Cancer is still a major cause of death worldwide, and the old ways of treating cancer have defects, such as systemic toxicity, quick drug resistance, and poor targeting. Given the favorable features of the tumour microenvironment, conventional therapy has shown limited efficacy, thus, new nanocarrier-based drug deliver...
Xin-Yu Yang· Theoretical and Natural Scie...· 0 citations
Tumor hypoxia critically drives the development of an immunosuppressive tumor microenvironment (TME) and accelerates tumor progression. Besides, hypoxia seriously restricts O2-dependent reactive oxygen species (ROS) generation, thereby severely compromising the therapeutic efficacy of photodynamic therapy (PDT). To a...
Chen-Lu Huang, Han-Yong Wang, Xin-Yu Yang et al.· ACS Nano· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.